FMC earnings analysis
What we found in FMC's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
FMC Corporation's Q1 2026 results showcased a strong revenue performance of $758.6 million, exceeding estimates, while EPS surpassed expectations with a loss of only -$0.023. The company has maintained its full-year revenue guidance, indicating resilience amid challenging market conditions.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Q1 2026 Revenue Beat
- FMC reported $758.6 million in revenue, surpassing estimates of $738.3 million.
- EPS Outperformance
- The company achieved an EPS of -$0.023, compared to an expected loss of -$0.38, reflecting a positive surprise of 0.94.
- Recovery in Revenue After Decline
- Q1 2026 revenue increased from $791 million in Q1 2025, indicating growth despite prior challenges.
- Strong Free Cash Flow
- FMC reported free cash flow of $378 million in Q4 2025, indicating improved cash generation prior to Q1 2026.
- Full-Year Revenue Guidance Maintained
- Revenue guidance for 2026 remains between $3.60 billion and $3.80 billion, reaffirming management's confidence.
- Improved Gross Margin
- Gross margin for Q1 2026 was reported at 40.0%, showing stability compared to previous quarters.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Significant Net Loss
- FMC continues to experience considerable net losses with an EPS loss of -$0.023 for Q1 2026.
- Declining Adjusted EBITDA
- Operating margin declined to 7.4% in Q1 2025, reflecting ongoing operational challenges.
- Cash Flow Concerns
- Despite a previous solid free cash flow in Q4 2025, Q1 2026 cash flow issues remain a concern with the company's negative performance in recent quarters.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-0.023
- Gross margin
- 40.0%
- Operating margin
- 7.4%
What they said about what is next.
Full-year guidance maintained despite expected declines in revenue and adjusted earnings.
The filing reads better than the one before it.
What came before.
- 10-K · February 27, 2026
- FMC positions itself as a tier‑one global agrochemicals leader with a concentrated, innovation‑led pipeline (16 actives in discovery; 19 in development) and core products (Rynaxypyr® ≈ $0.8B, Cyazypyr® ≈ $0.4B in 2025).…
- 10-Q · May 2, 2023
- FMC reported Q1 revenue of $1,344.3 million, essentially flat year-over-year (down $6.5M vs Q1 2022) while gross margin dollars increased to $581.3 million. Diluted EPS declined to $1.55 from $1.64 a year ago, and…
- 10-K · February 24, 2023
- FMC reports strong top-line momentum in 2022 (revenues grew approximately 15% year‑over‑year and 18% organically) driven by product launches and volume/price gains in North and Latin America, underpinned by a large…
- 10-Q · November 2, 2022
- FMC reported Q3 revenue of $1,377.2 million, up $183.2 million (+15.3%) versus Q3 2021, but gross margin narrowed to $477.5 million from $511.5 million and diluted EPS (net) fell to $0.95 from $1.24. Operating income…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing FMC makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever